InsiderTrades

Form 4 for COSM Cosmos Health Inc.

Accepted 2022-12-21 00:00:00 ET · period of report 2022-12-19 · accession 0001477932-22-009480 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-21 2022-12-19 COSM Siokas Grigorios CEO, Dir, 10% P - Purchase $11.50 +260.9K 1.13M +30% +$3.00M
D 2022-12-21 2022-12-19 COSM Siokas Grigorios CEO, Dir, 10% P - Purchase $11.50 +260.9K 260.9K New +$3.00M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $.001 par value 2022-12-19 P A 260,870 $11.50 1,130,774 D — — (F1) These shares were purchased by Mr. Siokas in a registered direct offering pursuant to the Company's "shelf" registration statement on Form S-3 (No. 333-267550) declared effective by the SEC on December 15, 2022. (F2) All share and per share amounts reflect a 1 for 25 reverse stock split effected on December 15, 2022 with the Secretary of State of Nevada.
2 Derivative Warrants 2022-12-19 P A 260,870 $11.50 260,870 D $11.50 · 2022-12-21 to 2027-12-21 260,870 Common Stock (F3) These warrants were purchased by Mr. Siokas in a private placement concurrent with the registered direct offering described in note (1) above.